Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Reports Decreased Q2 Revenues

NEW YORK, Aug. 5 (GenomeWeb News) - Transgenomic today reported decreased second-quarter revenues amid widened net losses.


The Omaha, Neb. company had revenues of $8.5 million for the quarter, compared to $9.4 million for the same period last year.


Losses totalled $4.7 million, compared to $4.0 million for the year-ago quarter.


R&D expenses decreased also, to $2.4 million, from $3.0 million in the same period last year.


As of June 30, the company had cash, cash equivalents, and short-term investments of $3.0 million.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.